{
  "query": "Paul Hudson",
  "rendered_query": "\"Paul Hudson\"",
  "total_results": 10,
  "texts": [
    "Executive Committee: Paul Hudson, CEO | Sanofi Paul Hudson Chief Executive Officer Paul Hudson, Chief Executive Officer At a Glance Date of birth October 14, 1967 Nationality British First elected or appointed September 2019 Last reappointment May 2022 Education and Business Experience Paul Hudson is reshaping Sanofi into a modern healthcare company with the ambition to transform the practice of medicine. Paul and the Sanofi teams are focusing efforts to discover, develop, manufacture, and make accessible breakthrough medicines and vaccines for people around the world. Under Paul√¢¬Ä¬ôs leadership, the company has prioritized social impact, focusing on company culture and putting health and environmental sustainability at the core of its long-term strategy. Paul joined Sanofi as CEO in September 2019. Previously, Paul was CEO of Novartis Pharmaceuticals from 2016 to 2019. His career in healthcare has spanned the globe, with roles in the US, Japan and Europe. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and served as president, AstraZeneca US and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synth√É¬©labo UK.√Ç Paul holds a degree in economics from Manchester Metropolitan University in the UK, and in July 2018 his alma mater awarded him an honorary Doctor of Business Administration for his achievements in industry.√Ç People are what drive me. I was drawn to healthcare so that I could positively impact people√¢¬Ä¬ôs lives. Paul Hudson Chief Executive Officer Contact information 46, avenue de la Grande Arm√É¬©e - 75017 Paris (France) Paul Hudson on LinkedIn Directorships & Appointments Inside the Sanofi Group Chief Executive Officer (Term expires 2026) Director Chairman of the Executive Committee Member of the Strategy Committee Meet the Sanofi Executive Committee Houman Ashrafian Executive Vice President, Head of Research and Development See more Natalie Bickford Executive Vice President, Chief People Officer See more Olivier Charmeil Executive Vice President, General Medicines See more Audrey Duval Executive Vice President, Corporate Affairs See more Brian Foard Executive Vice President, Head of Specialty Care See more Emmanuel Frenehard Executive Vice President, Chief Digital Officer See more Brendan O√¢¬Ä¬ôCallaghan Executive Vice President, Manufacturing and Supply See more Roy Papatheodorou Executive Vice President, General Counsel See more Madeleine Roach Executive Vice President, Business Operations See more Fran√É¬ßois Roger Executive Vice President, Chief Financial Officer See more Thomas Triomphe Executive Vice President, Vaccines See more",
    "Paul Hudson - Chief Executive Officer at Sanofi | LinkedIn Passer au contenu principal Identifiez-vous pour voir le profil complet de Paul S‚Äôidentifier Bon retour parmi nous E-mail ou t√©l√©phone Mot de passe Afficher Mot de passe oubli√©¬†? S‚Äôidentifier ou En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant ou Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Paul Hudson Identifiez-vous pour voir le profil complet de Paul S‚Äôidentifier Bon retour parmi nous E-mail ou t√©l√©phone Mot de passe Afficher Mot de passe oubli√©¬†? S‚Äôidentifier ou En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant ou Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Chief Executive Officer at Sanofi Paris et p√©riph√©rie Coordonn√©es Identifiez-vous pour voir le profil complet de Paul S‚Äôidentifier Bon retour parmi nous E-mail ou t√©l√©phone Mot de passe Afficher Mot de passe oubli√©¬†? S‚Äôidentifier ou En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant ou Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. 225¬†k¬†abonn√©s + de 500¬†relations Voir vos relations en commun Voir les relations en commun avec Paul S‚Äôidentifier Bon retour parmi nous E-mail ou t√©l√©phone Mot de passe Afficher Mot de passe oubli√©¬†? S‚Äôidentifier ou En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant ou Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Devenir membre pour voir le profil Message Identifiez-vous pour voir le profil complet de Paul S‚Äôidentifier Bon retour parmi nous E-mail ou t√©l√©phone Mot de passe Afficher Mot de passe oubli√©¬†? S‚Äôidentifier ou En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant ou Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Sanofi The Manchester Metropolitan University Signaler ce profil √Ä propos I was drawn to healthcare early in my career. While a lot has changed since I started as a pharmaceutical medical representative 30 years ago, I remain inspired everyday by the power of medicine and how new technology, like Artificial Intelligence, is helping advance scientific breakthroughs like never before. I am proud to lead Sanofi, a global healthcare company driven by one purpose: we chase the miracles of science to improve people‚Äôs lives. That means our teams are dedicated to transforming the practice of medicine by turning the impossible into the possible. As a leader, I firmly believe that making an impact starts with culture - how we empower and motivate each other to be the best version of ourselves. That includes giving our people access to cutting edge technologies that push the boundaries of science. Then, with open minds, we can fuel innovation and unleash potential that drives long-term success. What do I love most about my job? That even on a tough day, I am confident that our work is making a positive impact on our people, our patients and our society. Articles de Paul Beyond the Screen: Leveraging Tech to Unlock Happiness 29 ao√ªt 2025 Beyond the Screen: Leveraging Tech to Unlock Happiness Welcome to the second edition of The Co-Lab! As summer winds down, it‚Äôs a good time to reflect on how technology shapes‚Ä¶ 1‚ÄØ232 50¬†commentaires From Pit Stops to Patients: When Every Second Counts 5 juin 2025 From Pit Stops to Patients: When Every Second Counts Welcome to the first edition of The Co-Lab! In this newsletter, I‚Äôll be sitting down with visionary leaders from‚Ä¶ 2‚ÄØ988 128¬†commentaires Who Ignites Your Potential? 27 juin 2024 Who Ignites Your Potential? It‚Äôs the question at the center of our Paris 2024 campaign. Maybe it‚Äôs winning gold, or maybe it‚Äôs discovering the next‚Ä¶ 1‚ÄØ066 28¬†commentaires Shining a Light on Science and Innovation 25 janv. 2024 Shining a Light on Science and Innovation 2024 will be a year unlike any other for Sanofi. There are many reasons for this. 2‚ÄØ499 30¬†commentaires Celebrating Sports, Spirit and Shared Values 21 d√©c. 2023 Celebrating Sports, Spirit and Shared Values 2023 was a pivotal year for Sanofi. We made great strides in doing what we do best: chasing the miracles of science to‚Ä¶ 1‚ÄØ330 24¬†commentaires Our journey to become a science-led company 7 d√©c. 2023 Our journey to become a science-led company Almost four years ago exactly, we presented a six-year strategy aimed at putting Sanofi back on the map of the most‚Ä¶ 2‚ÄØ893 26¬†commentaires Giving our people the chance of a lifetime to give back 8 nov. 2023 Giving our people the chance of a lifetime to give back Next summer, all eyes will be on France for the Olympic and Paralympic Games Paris 2024. As thousands of athletes and‚Ä¶ 1‚ÄØ235 35¬†commentaires We Are Only as Good as the Sum of Our Parts 28 sept. 2023 We Are Only as Good as the Sum of Our Parts If you type ‚Äúteamwork + quote‚Äù into Google, it‚Äôs likely you‚Äôll end up finding a great quote from Michael Jordan. No‚Ä¶ 1‚ÄØ253 29¬†commentaires Let‚Äôs Fly the Meningitis Flag 28 ao√ªt 2023 Let‚Äôs Fly the Meningitis Flag When I joined Sanofi in September 2019, I was excited about diving into the world of prevention and vaccines. Four‚Ä¶ 2‚ÄØ078 33¬†commentaires 1 Year to Paris 2024: Ready, Set, Go! 26 juil. 2023 1 Year to Paris 2024: Ready, Set, Go! When we first announced our partnership with the Olympic and Paralympic Games Paris 2024, some people may have‚Ä¶ 2‚ÄØ853 59¬†commentaires Show more See all articles Activit√© Suivre Identifiez-vous pour voir le profil complet de Paul S‚Äôidentifier Bon retour parmi nous E-mail ou t√©l√©phone Mot de passe Afficher Mot de passe oubli√©¬†? S‚Äôidentifier ou En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant ou Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. When innovation is recognized, it‚Äôs a powerful reminder of why we do what we do: for the patients counting on us around the world.\n¬†\nWe're honored‚Ä¶ When innovation is recognized, it‚Äôs a powerful reminder of why we do what we do: for the patients counting on us around the world.\n¬†\nWe're honored‚Ä¶ Aim√© par Paul Hudson Behind every breakthrough, there‚Äôs a story.\n¬†\nFrom the 500¬†million people around the world who have experienced a respiratory disease to the‚Ä¶ Behind every breakthrough, there‚Äôs a story.\n¬†\nFrom the 500¬†million people around the world who have experienced a respiratory disease to the‚Ä¶ Aim√© par Paul Hudson Today, I got my flu shot, a small act to help protect myself, my colleagues üë©‚Äçüíºüë®‚Äçüíºand my loved onesüíú.\n¬†\nüíâüåç A simple act that protects‚Ä¶ Today, I got my flu shot, a small act to help protect myself, my colleagues üë©‚Äçüíºüë®‚Äçüíºand my loved onesüíú.\n¬†\nüíâüåç A simple act that protects‚Ä¶ Aim√© par Paul Hudson S‚Äôinscrire pour voir toute l‚Äôactivit√© Exp√©rience Chief Executive Officer Sanofi sept. 2019 - aujourd‚Äôhui 6¬†ans 3¬†mois Paris Area, France CEO, Novartis Pharmaceuticals Novartis juil. 2016 - juin 2019 3¬†ans Basel Area, Switzerland AstraZeneca 10¬†ans President, AstraZeneca US and Executive Vice President, North America AstraZeneca janv. 2013 - juin 2016 3¬†ans 6¬†mois Delaware President, AstraZeneca Japan AstraZeneca K.K. mars 2011 - janv. 2013 1¬†an 11¬†mois Japan Marketing Company President, Spain AstraZeneca juin 2008 - mars 2011 2¬†ans 10¬†mois Spain Vice President and Primary Care Director AstraZeneca juil. 2006 - juin 2008 2¬†ans UK Formation The Manchester Metropolitan University Degree Economics 1987 - 1990 Chartered Institute of Marketing Diploma Marketing Prix et distinctions Honorary Doctorate in Business Administration The Manchester Metropolitan University juil. 2018 Organisations PhRMA Treasurer and Member of the Board f√©vr. 2024 - aujourd‚Äôhui PhRMA Member of the Board oct. 2019 - f√©vr. 2024 EFPIA Member of the Board 2017 - juin 2019 Plus d‚Äôactivit√©s de Paul Today we announced Sanofi's Q3 results - proof of our continued growth momentum.\n\nIn addition to our strong sales growth of 7%, here's what stands‚Ä¶ Today we announced Sanofi's Q3 results - proof of our continued growth momentum.\n\nIn addition to our strong sales growth of 7%, here's what stands‚Ä¶ Partag√© par Paul Hudson I am proud to share the news of Sanofi‚Äôs additional $625 million, multi-year capital commitment to Sanofi Ventures. This investment strengthens our‚Ä¶ I am proud to share the news of Sanofi‚Äôs additional $625 million, multi-year capital commitment to Sanofi Ventures. This investment strengthens our‚Ä¶ Partag√© par Paul Hudson We're boosting our commitment to healthcare innovation with a $625 million investment in Sanofi Ventures, now managing over $1.4 billion. This‚Ä¶ We're boosting our commitment to healthcare innovation with a $625 million investment in Sanofi Ventures, now managing over $1.4 billion. This‚Ä¶ Aim√© par Paul Hudson Today marks a significant milestone in our journey to improve the lives of people living with rare diseases. The FDA has approved our new treatment‚Ä¶ Today marks a significant milestone in our journey to improve the lives of people living with rare diseases. The FDA has approved our new treatment‚Ä¶ Aim√© par Paul Hudson Today we had the privilege of welcoming the amazing Blueprint Medicines  team to Sanofi. This strategic acquisition not only bolsters our rare‚Ä¶ Today we had the privilege of welcoming the amazing Blueprint Medicines  team to Sanofi. This strategic acquisition not only bolsters our rare‚Ä¶ Aim√© par Paul Hudson AI's transformation of our industry is undeniable, but that's only half the story. The real breakthrough happens at the intersection of human‚Ä¶ AI's transformation of our industry is undeniable, but that's only half the story. The real breakthrough happens at the intersection of human‚Ä¶ Aim√© par Paul Hudson It was great to have the opportunity to spend some time at the opening day of¬†Viva Technology¬†in Paris which is once again bringing together‚Ä¶ It was great to have the opportunity to spend some time at the opening day of¬†Viva Technology¬†in Paris which is once again bringing together‚Ä¶ Aim√© par Paul Hudson It was certainly a weekend like no other! I had the privilege of attending the 93rd 24 Hours of Le Mans. The courage and resilience of all the‚Ä¶ It was certainly a weekend like no other! I had the privilege of attending the 93rd 24 Hours of Le Mans. The courage and resilience of all the‚Ä¶ Aim√© par Paul Hudson Voir le profil complet de Paul D√©couvrir vos relations en commun √ätre mis en relation Contacter Paul directement Devenir membre pour voir le profil complet S‚Äôidentifier Tenez-vous au courant des √©volutions de votre monde professionnel S‚Äôidentifier En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Nouveau sur LinkedIn¬†? Inscrivez-vous maintenant Autres profils similaires Mike Anderson Mike Anderson Chief Executive Officer at Valperian Pharmaceuticals LLC √éle de Sullivan, SC Se connecter Philippe Pourquier Philippe Pourquier Montpellier et p√©riph√©rie Se connecter eric Grossat eric Grossat Chief Executive Officer at HOPES, specialized in value based healthcare. Part of the LOGEX GROUP Madrid Se connecter Olivier Schiller Olivier Schiller France Se connecter Ghjuvan Micaelu Grimaud Ghjuvan Micaelu Grimaud Malm√∂ ou Malmoe Se connecter Hartmut J. Ehrlich Hartmut J. Ehrlich Royaume-Uni Se connecter Alexandre Durand-Salmon Alexandre Durand-Salmon Metz et p√©riph√©rie Se connecter David Loew David Loew France Se connecter Celia Belline Celia Belline Montpellier et p√©riph√©rie Se connecter Arezki BELDJENNA Arezki BELDJENNA Chief Executive Officer AMPHAR TECH SYSTEMS Paris et p√©riph√©rie Se connecter Joseph Saba Joseph Saba Paris et p√©riph√©rie Se connecter Thomas Seoh Thomas Seoh Chief Executive Officer at Faust Pharmaceuticals S.A. Strasbourg et p√©riph√©rie Se connecter Alexis PEYROLES Alexis PEYROLES Paris et p√©riph√©rie Se connecter Remi Bastien Remi Bastien Saint-Beauzire Se connecter Vincent Charlon Vincent Charlon France Se connecter Manuel Silva Manuel Silva Chief Executive Officer  at BioKawthar Technologies Paris et p√©riph√©rie Se connecter Luca Maciocco Luca Maciocco ecoVita CEO, Project Engineer&Manager at newcleo Italie Se connecter Arnaud Foussat Arnaud Foussat Valbonne Se connecter Sophie Wilford Sophie Wilford Lanton Se connecter Jean-Yves Renault Jean-Yves Renault Paris et p√©riph√©rie Se connecter Afficher plus de profils Afficher moins de profils Autres personnes nomm√©es Paul Hudson Paul Hudson Austin, TX Paul Hudson Miami, FL Paul Hudson Londres Paul Hudson Royaume-Uni 791 autres personnes nomm√©es Paul Hudson sont sur LinkedIn Autres personnes nomm√©es Paul Hudson Accepter et s‚Äôinscrire sur LinkedIn En cliquant sur Continuer pour vous inscrire ou vous identifier, vous acceptez les Conditions d‚Äôutilisation , la Politique de confidentialit√© et la Politique relative aux cookies de LinkedIn. Identifiez-vous pour voir le profil complet de Paul S‚Äôidentifier Bon retour parmi nous E-mail ou t√©l√©phone Mot de passe Afficher Mot de passe oubli√©¬†? S‚Äôidentifier ou En cliquant sur Cont",
    "About Paul Hudson ‚Äì¬†the creator and editor of Hacking with Swift NEW BOOK: Code got you started. This gets you paid . >> About the author CODER / WRITER / SPEAKER I've developed software for a huge range of devices, including iPhones, iPads, Apple Watch, Apple TV, Android, Windows, Windows Mobile, Xbox 360, and Linux, using languages like Swift, Objective-C, Python, PHP, Java, C#, and more. Each platform has its own appeal; each platform has something I've learned from. JOURNALISM I spent eight years in computer journalism, writing features and tutorials for Linux Format, MacFormat, TechRadar, .net, and others. ENTERPRISE When I switched to full time iOS coding, I built apps that were enjoyed by over 30 million users, including UBS, Fender, and PlayStation. PERSONAL In my spare time I've developed over 100 apps for iOS and Android. My tools have been used by Apple, Verizon, Autodesk, GE, and others. BOOKS Writing is now my full-time job once again, and I've authored over 20 books on iOS, macOS, watchOS, React, PHP, Linux, and more. Want to get in touch? You can email me at paul@hackingwithswift.com or tweet me @twostraws . I'm happy to deliver talks and workshops at conferences, or be a guest on podcasts ‚Äì¬†let me know how I can help! Tips for success I've lost track how many people have emailed me in the past asking for my secrets to success, as if I'm some sort of Tibetan monk guarding mysteries. I'm not; I'm a programmer just like you, although it's possible I've been doing it longer. That being said, I've picked up some tips along the way that can help you learn more efficiently. I don't claim these were invented by me ‚Äì in fact, quite the opposite! ‚Äì but here they are, in no particular order: To be a programmer you just need to program. There's no rite of passage, there's no graduation, and there's no certification ‚Äì¬†programmers are people who program, regardless of platform and regardless of language. As soon as you start writing code for one of my tutorials, you've made it - good job! The best way to get started learning is just by diving in. That means launching a code editor such as Xcode, and get busy trying to make something. But remember, you're not alone: there are many tutorials you can follow, including my own, and I encourage you to follow one of them to help you learn in a more structured way. Always ask questions. There are so many generous, patient people in our community who will go out of their way to help you, but they aren't magically able to notice people who need assistance. So, learn to ask questions: explain what you want, what you know, and what you've tried ‚Äì¬†that's usually enough to get some helpful pointers towards a solution. Be ready to read. Some people tell me they don't like reading books and instead prefer videos, but the blunt truth is that once you progress past the early stages the vast majority of documentation is available solely as text, so you'll struggle if you're unable to read effectively. Don't try to memorize things. A large chunk ‚Äì¬†certainly well over half ‚Äì¬†of what you'll learn isn't worth memorizing, and the rest will be repeated so often that you'll memorize it by brute force over time. Learn to rely on Xcode's autocomplete system; it's a huge crutch for all of us. Follow the classic path to success: \"make it work, make it right, make it fast.\" That means don't worry if the first version of your code is shocking to the point that it probably breaks the Geneva convention ‚Äì¬†if it proves your idea is sound, or generates enough insight to help you make a second, better pass, then it's done its job. There is no silver bullet language or platform. Almost all languages and all platforms have something of merit, and if you're able to sample a variety you'll be a better developer for it. While it can sometimes be fun to poke at other programmers, don't indulge in language snobbery ‚Äì¬†it's a pretty tedious look. Build on your interests. So, take whatever coding ability you have and mash it up with whatever personal interests you have, and build an app that combines the two. Trust me on this: if you build an app that solves a problem you have, you can be guaranteed there are 100,000 other folks out there who have the same problem and would pay for your solution. Support my work If you're enjoying Hacking with Swift there are three ways you can help support my work so that I can continue to write news, tutorials, and books. First, you can buy one of my books. I have a huge selection to choose from, and there's something for every level of developer. You can browse the full list of books in my store . Second, you can add a link to Hacking with Swift from your website. This helps others find the site, but also helps me rank higher on Google so more people find me by chance. You can find some suggested links and text here . Third, you can write a tweet recommending the site. I don't care whether you have 5 followers, 50, or 50,000, every tweet helps me build awareness. After all, happy readers are the only marketing I have! Want to get in touch? You can email me at paul@hackingwithswift.com or tweet me @twostraws . I'm happy to deliver talks and workshops at conferences, or be a guest on podcasts ‚Äì¬†let me know how I can help! You are not logged in Log in or create account Link copied to your pasteboard.",
    "JavaScript is not available. We‚Äôve detected that JavaScript is disabled in this browser. Please enable JavaScript or switch to a supported browser to continue using x.com. You can see a list of supported browsers in our Help Center. Help Center Terms of Service Privacy Policy Cookie Policy Imprint Ads info ¬© 2025 X Corp. Something went wrong, but don‚Äôt fret ‚Äî let‚Äôs give it another shot. Try again Some privacy related extensions may cause issues on x.com. Please disable them and try again.",
    "Paul Hudson - YouTube About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features NFL Sunday Ticket ¬© 2025 Google LLC",
    "Paul Hudson (businessman) - Wikipedia Jump to content From Wikipedia, the free encyclopedia British pharmaceutical executive (born 1967) Paul Hudson Hudson in 2023 Born ( 1967-10-14 ) 14 October 1967 [ 1 ] Nationality British Education Manchester Metropolitan University Title CEO, Sanofi Term September 2019- Predecessor Olivier Brandicourt Children 3 Paul Hudson (born 14 October 1967) [ 2 ] is a British businessman, and the chief executive (CEO) of Sanofi , the world's fifth largest pharmaceutical company by prescription drug sales. [ 3 ] Early life [ edit ] Hudson earned a degree in economics from Manchester Metropolitan University , and a diploma in marketing from the Chartered Institute of Marketing . [ 1 ] Career [ edit ] Hudson has been CEO of Sanofi since September 2019. [ 4 ] [ 5 ] [ 6 ] Hudson was previously CEO of Novartis Pharmaceuticals, and before that AstraZeneca , rising to president, AstraZeneca United States and Executive Vice President, North America. [ 6 ] [ 7 ] [ 8 ] Recognition [ edit ] Hudson was awarded an honorary doctorate by Manchester Metropolitan University in 2018. [ 1 ] [ 9 ] Personal life [ edit ] Hudson has three children with his wife Sandra and is an \"ardent Manchester United football fan\". [ 1 ] References [ edit ] ^ a b c d \"Paul Hudson - Sanofi\" . www.sanofi.com . ^ \"Paul Hudson - Sanofi\" . www.sanofi.com . Retrieved 29 January 2021 . ^ Willsher, Kim (26 January 2021). \"French self-esteem hit after Pasteur Institute abandons Covid vaccine\" ‚Äì via www.theguardian.com. ^ \"Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved\" . Fortune . ^ \"Sanofi's CEO on a big acquisition, long-term strategy, and vaccines\" . 17 August 2020. ^ a b \"Global Proof of Concept: Q&A with Paul Hudson | Thought Leadership\" . Russell Reynolds Associates . Archived from the original on 24 February 2021 . Retrieved 26 January 2021 . ^ \"AstraZeneca announces changes to Senior Executive Team\" . Fiercepharma . ^ \"Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis\" . Novartis . Retrieved 24 April 2023 . ^ \"Paul Hudson\" . Manchester Metropolitan University . Retrieved 24 April 2023 . Business positions Preceded¬†by Olivier Brandicourt CEO of Sanofi 2019‚Äìpresent Succeeded¬†by Incumbent v t e Sanofi Predecessors Hoechst Rh√¥ne-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt Main products Cardiovascular Aprovel CoAprovel Tritace Thrombosis Plavix Clexane Oncology Taxotere Eloxatin Diabetes Amaryl Apidra Lantus Central nervous system Depakine Chrono Internal medicine Actonel Arava Avil Avipect Bi-Profenid Bronchicum Claforan Daonil Flagyl Hemoclar Lanzor Lasix Maalox Maalox Plus Proctosedyl Targocid Tavanic Telfast Trental Subsidiaries Chattem Brands Allegra Allegra-D Gold Bond ACT Mouthwash Balmex Diaper Rash Ointment Rolaids Cortizone-10 Flexall IcyHot Sun-In Ultra Swim Pamprin Premsyn Kaopectate Dexatrim Aspercreme Selsun Blue Nasacort Unisom Capzasin Benzodent Herpecin-L Garlique New Phase Others Ablynx Bioverativ Genzyme Kadmon Corporation Sanofi Pasteur Shantha Biotechnics Retrieved from \" https://en.wikipedia.org/w/index.php?title=Paul_Hudson_(businessman)&oldid=1312716298 \" Categories : Living people British chief executives in the health care industry Alumni of Manchester Metropolitan University Sanofi people Novartis people AstraZeneca people GSK plc people 1967 births Hidden categories: Articles with short description Short description matches Wikidata Use dmy dates from January 2021 Use British English from January 2021 All Wikipedia articles written in British English Articles with hCards Template:Succession box: 'after' parameter includes the word 'incumbent' S-aft: 'after' parameter includes the word 'incumbent' Search Search Paul Hudson (businessman) 2 languages Add topic",
    "Paul Hudson (@twostraws@mastodon.social) - Mastodon To use the Mastodon web application, please enable JavaScript. Alternatively, try one of the native apps for Mastodon for your platform.",
    "Paul Hudson | Flickr Explore What‚Äôs New New! Recent Photos Trending Events The Commons Flickr Galleries World Map Camera Finder New! Flickr Blog Prints The Print Shop Prints & Wall Art Photo Books ‚ú® Get Pro Pro Plans Stats Dashboard Get Auto-Uploadr Log In Sign Up ‚ú® Get Pro Log In Explore What‚Äôs New New! Camera Finder New! Trending Events The Commons Flickr Galleries Flickr Blog The Print Shop Prints & Wall Art Photo Books About Jobs Blog Advertise Developers Guidelines Help Privacy Legal Terms Cookies English Paul Hudson Follow p_a_h 499 Followers ‚Ä¢ 197 Following 204,276 Photos United Kingdom Joined 2005 Paul Hudson p_a_h 499 Followers ‚Ä¢ 197 Following 204,276 Photos United Kingdom Joined 2005 Follow Save Cancel Drag to set position! About Photostream Albums Faves Galleries Groups This user has no public photos 1 2 3 4 5 6 7 ‚Ä¢‚Ä¢‚Ä¢ 2042 2043",
    "Paul D. Hudson: Miller Canfield Cookie Settings Search Menu ‰∏≠Êñá Polski Client Login Paul D. Hudson Principal Appeals Section Chair Email vCard Print Profile Print Brief Profile Office Grand Rapids T: +1.616.776.6303 O: +1.616.454.8656 F: +1.616.776.6322 Share Services Litigation and Dispute Resolution Appeals Criminal Defense Litigation Industries Higher Education Education Georgetown University Law Center, J.D., 2006 Cornell University, B.A. 2003 Bar Admissions Michigan Court Admissions U.S. Supreme Court U.S. Court of Appeals Sixth¬†Circuit Third Circuit U.S. District Courts Eastern District of Michigan Western District of Michigan Northern District of Indiana Profile Experience Honors & Leadership Publications & Events News Paul chairs the firm's Appeals group and focuses his practice on appellate matters in the state and federal appeals courts. He has argued more than 50 appeals in appellate courts across the country, including the Michigan Supreme Court, the Michigan Court of Appeals, and the United States Court of Appeals for the Sixth Circuit. He serves as a lead appellate counsel for a large automotive OEM in appeals throughout the Midwest, and lead appellate counsel for a large insurer in the Michigan appeals courts. He also represents individual clients in cases ranging from property and contract disputes to federal criminal and habeas appeals. He is admitted to practice in the United States Supreme Court and has represented clients at the writ of certiorari stage. Paul also maintains an active amicus curiae practice and serves as amicus counsel for the Michigan Manufacturers Association, a leading trade organization and a prominent voice in the Michigan appellate courts. Paul uses this deep and varied appellate experience to defend our clients' hard-fought victories on appeal and to overturn unfavorable decisions from the lower courts. Paul is known for his clear, concise, and persuasive writing style. A national legal writing expert recently conducted a blind study of merits briefs filed in the Michigan Supreme Court and concluded that \"one name is coming out on top: Paul Hudson.\" In 2016, Paul won the Michigan Defense Trial Counsel's Golden Gavel Award, which is given annually to a lawyer who \"exemplifies significant contribution to professionalism and courtesy in the practice of law and [promotes] the image and honorable reputation of the profession.\" Paul is active in state and federal bar associations and was appointed by the Chief Judge of the Sixth Circuit to serve as the chair of the Advisory Committee on Rules, one of just three Michigan lawyers on the Committee. He has also served on the State Bar of Michigan's Appellate Practice Council and the American Bar Association's Appellate Practice Committee. Paul was the Editor-in-Chief and Publications Chair of the State Bar of Michigan Litigation Journal, and co-authored the Michigan chapter of a leading treatise on commercial disputes, \"Business Torts: A Fifty State Guide.\" In addition to his busy practice, Paul serves the community as a member of the Board of Directors for Goodwill Industries of Southwest Michigan and as a member of Miller Canfield's Pro Bono Committee. Paul graduated cum laude from Georgetown University Law Center, where he was a member of the law review. He received a B.A. in Government and Philosophy from Cornell University, where he played as a catcher on the baseball team. Before joining Miller Canfield, Paul served as a law clerk for the Honorable Raymond M. Kethledge on the Sixth Circuit. Representative Matters Automotive Manufacturer Tax Dispute Successfully argued an appeal on behalf of an automotive manufacturer seeking a tax refund from the Department of Treasury. Automotive Supplier Warranty Dispute Successfully represented a large automotive supplier in a $50 million warranty dispute. Individual Criminal Defense Appeal Briefed and argued a criminal-procedure issue of first impression in the Michigan Court of Appeals. Defense Contractor Whistleblower Case Conducted internal investigation of a defense contractor relating to allegations of fraud by a whistleblower. Agricultural Supplier Whistleblower Case Conducted internal investigation of a large¬†agricultural supplier relating to¬†allegations of fraud by a¬†whistleblower. Federal Habeas Corpus Petitioner Appeal Briefed and argued complex habeas corpus appeal in the U.S. Court of Appeals for the Sixth Circuit. Individual Federal Criminal Trial Obtained a not-guilty verdict on the sole contested charge as co-counsel in a federal drug-distribution and firearms jury trial. Law Firm Fraud and Malpractice Dispute Won dismissal of multi-million-dollar fraud and malpractice claims against a foreign law firm. Reported and Published Decisions Ford Motor Co. v. Department of Treasury, __ NW.2d __, 2014 WL 2894925 (Mich 2014) Successfully argued an appeal on behalf of an automotive manufacturer seeking a tax refund from the Department of Treasury. Jackson v. Sedgwick Claims Claims Management, __ F.3d __ (2013) Successfully defended a worker's compensation claims administrator against allegations of civil RICO violations. Case was decided by Sixth Circuit en banc. MacDonald v. Thomas M. Cooley Law School , _F.3d_ (2013) Successfully represented a law school in a purported $300 million class action brought by graduates alleging fraud and violations of the Michigan Consumer Protection Act. Rudisill v. Ford Motor Co. , 709 F.3d 595 (6th Cir. 2013) Successfully argued an appeal involving a claim brought under the Ohio intentional-tort statute arising out of a factory accident. Mack Trucks Inc. v. BorgWarner Turbo Systems, Inc. , 508 F. App‚Äôx 180 (3d Cir. 2012) Successfully represented a turbocharger supplier against a $50 million warranty claim brought by a large truck manufacturer. Estate of David Geller v. Ellis Seddon Trust Successfully argued an appeal dismissing an action under Michigan‚Äôs corporate-dissolution statute. Thomas M. Cooley Law School v. John Doe 1 , 833 N.W.2d 331 (Mich. App. 2013) Represented law school in an appeal setting the standard in Michigan for discovery of the identity of an anonymous internet defamation defendant. Michigan One Funding, LLC v. MacLean , 2012 WL 4210424 (Mich. App. 2012) Argued appeal involving retention of confidential documents by a company executive after termination. Kennedy v. Warren , 428 F. App‚Äôx 517 (6th Cir. 2011) Briefed and argued a complex habeas corpus appeal involving changes to Confrontation Clause law. People v. Klees , 2011 WL 2342707 (Mich. App. 2011) Briefed and argued a criminal-procedure issue of first impression in the Michigan Court of Appeals. United States v. Wallace , No. 10-cr-20664 (E.D. Mich. 2012) Obtained a non-guilty verdict on the sole contested charge as co-counsel in a federal drug distribution and firearms jury trial. Urban Global v. DibbsBarker , 2011 WL 2802904 (E.D. Mich. 2011) Won dismissal of multi-million-dollar fraud and malpractice claims against an Australian law firm. Honors Grand Rapids Magazine , Top Lawyers, Appellate Law, 2024 The Fellows of the Michigan State Bar Foundation Best Lawyers in America, Appellate Law and Commercial Litigation, 2016-present State Bar of Michigan Pro Bono Honor Roll, 2021 DBusiness Magazine, Top Lawyers, Appellate Law, 2020-2023 Michigan Super Lawyers, Appellate, 2023-2025; Rising Star, 2011-2022 Michigan Lawyers Weekly, Up and Coming Lawyers, 2013 Leading Lawyers, Civil Appellate Law, Commercial Litigation, Criminal Appellate Law, Criminal Defense Law: White Collar, 2014‚Äìpresent Professional Activities Sixth Circuit Advisory Committee on Rules, Chair American Bar Association, Appellate Practice Committee, Former Membership and Diversity Chair State Bar of Michigan, Appellate Practice Council State Bar of Michigan, Former Litigation Section Council State Bar of Michigan, Litigation Newsletter, Former Editor-in-Chief Civic, Cultural & Social Activities Duffy Daugherty Memorial Award, Board of Directors Goodwill Industries of Southwest Michigan, Board of Directors Speeches \"Using Friend of the Court Briefs to Protect Your Organization,\" Miller Canfield, May 9, 2013 \"Winning Your Appeal,\" Miller Canfield Cappuccino with Counsel Series, May 9, 2012 Publications \"Business Torts:¬†A Fifty State Guide\" (Co-author of Michigan chapter), Aspen Publishers, 2014 \"Understanding¬†the Changes to the Rules of Civil Procedure: Amendments Move E-Discovery to the Forefront of Civil Litigation,\" (Co-author),¬†2¬†CONSUMER FIN. L. Q. REP. 229 (2007) Events Using Friend of the Court Briefs to Protect Your Organization Cappuccino with Counsel: Winning Your Appeal Articles Thinking Ahead: Why You Should Consider Including an Appellate Lawyer on Your Trial Team U.S. Supreme Court Rundown Best Lawyers in America Recognizes 102 Miller Canfield Attorneys Super Lawyers Recognizes 41 Miller Canfield Attorneys Miller Canfield Earns 77 Top Lawyers Honors Super Lawyers Recognizes 32 Miller Canfield Attorneys on 2024 List 103 Miller Canfield Attorneys Named Best Lawyers, Ones to Watch 86 Miller Canfield Attorneys Recognized in Top Lawyers 110 Miller Canfield Attorneys Earn Best Lawyers Recognition Super Lawyers Recognizes 38 Miller Canfield Attorneys Seventy-One Miller Canfield Attorneys Named in DBusiness 2023 Top Lawyers Michigan State Bar Foundation Names Eight Miller Canfield Fellows 109 Miller Canfield Attorneys Named in Best Lawyers and Ones to Watch 46 Miller Canfield Lawyers Named in 2022 Super Lawyers and Rising Stars Sixty-Five Miller Canfield Attorneys Named in DBusiness Top Lawyers 106 Miller Canfield Attorneys Named Among Best Lawyers in America 53 Miller Canfield Lawyers Named in Super Lawyers and Rising Stars DBusiness Magazine Names 70 Miller Canfield Attorneys on Top Lawyers List 57 Miller Canfield Lawyers Named in Super Lawyers and Rising Stars Miller Canfield Lawyers Named Among DBusiness Top Lawyers Paul Hudson to Receive Golden Gavel Award Miller Canfield Lawyer Paul Hudson Named One of Michigan Lawyers Weekly's ‚ÄúUp & Coming Lawyers‚Äù Miller Canfield Wins Appeal of Civil RICO Case Before Entire Sixth Circuit; Decision is an Important Win for Employers in Worker‚Äôs Compensation Cases We use cookies to improve the functionality of our website and make your web experience better. For more information, please visit our privacy policy . Manage Cookies Reject All Cookies Accept All Cookies Cookie Preference Center Close Your Privacy When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use Cookies, please see our Privacy Policy . Strictly Necessary Cookies Always Active Necessary cookies enable core functionality such as security, network management, and accessibility. These cookies may only be disabled by changing your browser settings, but this may affect how the website functions. Functional Cookies Always Active Some functions of the site require remembering user choices, for example your cookie preference, or keyword search highlighting. These do not store any personal information. Form Submissions Always Active When submitting your data, for example on a contact form or event registration, a cookie might be used to monitor the state of your submission across pages. Analytical Cookies On Off Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level. Powered by Confirm My Choices",
    "Error fetching content: 403 Client Error: Forbidden for url: https://www.dwt.com/people/h/hudson-paul-b"
  ],
  "links": [
    "https://www.sanofi.com/en/our-company/governance/executive-committee/paul-hudson",
    "https://fr.linkedin.com/in/paulhudsonprofile",
    "https://www.hackingwithswift.com/about",
    "https://x.com/twostraws?lang=en",
    "https://www.youtube.com/paulhudson",
    "https://en.wikipedia.org/wiki/Paul_Hudson_(businessman)",
    "https://mastodon.social/@twostraws",
    "https://www.flickr.com/photos/pahudson/",
    "https://www.millercanfield.com/PaulHudson",
    "https://www.dwt.com/people/h/hudson-paul-b"
  ]
}